Corcept Therapeutics
CORT
#2078
Rank
ยฃ6.81 B
Marketcap
ยฃ64.63
Share price
1.71%
Change (1 day)
38.79%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.31 Billion

According to Corcept Therapeutics 's latest financial reports the company has ยฃ0.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.30 B5.69%
2023-12-31ยฃ0.28 B-19%
2022-12-31ยฃ0.35 B115.46%
2021-12-31ยฃ0.16 B-48.78%
2020-12-31ยฃ0.32 B53.63%
2019-12-31ยฃ0.21 B29.2%
2018-12-31ยฃ0.16 B148.06%
2017-12-31ยฃ65.66 M57.21%
2016-12-31ยฃ41.76 M53.07%
2015-12-31ยฃ27.28 M75.19%
2014-12-31ยฃ15.57 M-53.19%
2013-12-31ยฃ33.26 M-42.2%
2012-12-31ยฃ57.55 M125.72%
2011-12-31ยฃ25.5 M60.16%
2010-12-31ยฃ15.92 M7.95%
2009-12-31ยฃ14.74 M18.06%
2008-12-31ยฃ12.49 M42.91%
2007-12-31ยฃ8.74 M81.07%
2006-12-31ยฃ4.82 M-71.37%
2005-12-31ยฃ16.86 M-13.44%
2004-12-31ยฃ19.48 M201.01%
2003-12-31ยฃ6.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ13.93 B 4,301.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.38 B 3,813.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ7.32 B 2,212.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ7.44 B 2,250.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.24 B 3,453.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.67 B 4,219.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ69.39 M-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ0.19 B-38.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.10 B 250.46%๐Ÿ‡บ๐Ÿ‡ธ USA